• Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch

Scientific Inquirer

  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

COVID-19

  • COVID-19 vaccine builds powerful immune response in First Nations peoples
    May 31, 2023

    COVID-19 vaccine builds powerful immune response in First Nations peoples

    bricemarsters
  • Breastfeeding increased by 2 weeks when mothers stayed home
    May 24, 2023

    Breastfeeding increased by 2 weeks when mothers stayed home

    bricemarsters
  • Tracking SARS-CoV-2 in Mozambique
    May 20, 2023

    Tracking SARS-CoV-2 in Mozambique

    bricemarsters
  • Low levels of vitamin D linked to long COVID
    May 20, 2023

    Low levels of vitamin D linked to long COVID

    bricemarsters
  • Researchers discovered that various species share a similar mechanism of molecular response to nanoparticles
    May 18, 2023

    Researchers discovered that various species share a similar mechanism of molecular response to nanoparticles

    bricemarsters
  • Risk of long COVID higher for people living in most deprived areas
    May 14, 2023

    Risk of long COVID higher for people living in most deprived areas

    bricemarsters
  • Study identifies messages about vaccinating children against COVID-19 that resonate best with vaccine-hesitant parents
    May 10, 2023

    Study identifies messages about vaccinating children against COVID-19 that resonate best with vaccine-hesitant parents

    bricemarsters
  • UCLA researchers find possible link between self-perceived cognition deficits and symptomatic long COVID
    May 10, 2023

    UCLA researchers find possible link between self-perceived cognition deficits and symptomatic long COVID

    bricemarsters
  • What really killed COVID-19 patients: it wasn’t a cytokine storm
    May 10, 2023

    What really killed COVID-19 patients: it wasn’t a cytokine storm

    bricemarsters
  • UMass Chan scientists deliver siRNA therapy to lung
    May 6, 2023

    UMass Chan scientists deliver siRNA therapy to lung

    bricemarsters
Previous Page
1 … 5 6 7 8 9 … 27
Next Page

Categories

Asia.

North America.

Europe.

Africa.

South America.

Australia.

Science For All, Not Just The Few.

Subscribe to our newsletters. We’ll keep you in the loop.

  • Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch
  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

Designed with WordPress

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
 

Loading Comments...